55 Years to 90 Years
Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD)
Observational, Imaging Study
Participants will undergo multiple clinical and cognitive assessments over time. These may include computerized cognitive tests, blood biomarker and genetic tests, imaging scans and cerebral spinal fluid (CSF) collection for up to 5 years.
Cognitively normal (CN), mild cognitive impairment (MCI), and mild AD dementia participants. We invite individuals with or without subjective memory complaints. A complete list of criteria may be discussed with the study team.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.